BIOOCUS Biotech Ltd. has pioneered the development of cutting-edge cellular immunotherapy with NK cells to revolutionize the treatment of cancer and other immune-related diseases. Our innovative technology harnesses the power of natural killer (NK) cells to target and destroy cancerous cells, offering a promising alternative to traditional treatments, Our flagship product, NK-Immunocell, is a novel cellular therapy that unleashes the potential of NK cells in the fight against cancer. Through our proprietary processes, we are able to isolate and expand NK cells from healthy donors, and then infuse them into patients to bolster their immune response. This personalized approach has shown great promise in clinical trials, demonstrating significant efficacy with minimal side effects
Please feel free to give your inquiry in the form below We will reply you in 24 hours